Literature DB >> 8129613

The genome of feline immunodeficiency virus.

T Miyazawa1, K Tomonaga, Y Kawaguchi, T Mikami.   

Abstract

Feline immunodeficiency virus (FIV) is a member of the genus Lentivirus of the family Retroviridae. FIV can infect T lymphocytes and monocytes/macrophages in vitro and in vivo, and causes an acquired immunodeficiency syndrome-like disease in cats. Several isolates of FIV from geographically distant countries have been molecularly cloned. There is considerable heterogeneity especially in Env gene among the FIV isolates and they can be divided into two or more subgroups. Like other lentiviruses, FIV has a complex genome structure. Gag gene encodes matrix, capsid and nucleocapsid proteins, and Pol gene encodes protease, reverse transcriptase, dUTPase and integrase. The dUTPase is not present in the primate lentiviruses but present in the non-primate lentiviruses. Env gene encodes surface and transmembrane envelope glycoproteins. In addition to the structural and enzymatic proteins, at least three more genes (Vif, ORF A, Rev) are present in FIV. Vif is related to the infectivity of the cell-free viruses. Rev functions in the stability and transport of incompletely spliced viral RNAs from the nucleus to cytoplasm and is indispensable for virus replication. Although the Tat protein of the primate lentiviruses is essential for virus replication, ORF A (putative Tat gene) of FIV is not essential for virus replication in established feline T lymphoblastoid cell lines. However, the ORF A gene product is related to the efficient replication of the virus in primary peripheral blood lymphocytes. In the long terminal repeat (LTR) of FIV, there are many putative binding sites for enhancer/promoter proteins. Among these binding sites, the putative AP-1 site is important for basal promoter activity of the LTR and responsible for the T cell activation signal through protein kinase C, however the site is not required for the virus replication in established feline T lymphoblastoid cell lines. Comparative study of the molecular biology of lentiviruses revealed that the genome structure, splicing pattern and functional enhancer protein-binding sites of FIV are more similar to those of the ruminant lentiviruses than those of the primate lentiviruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129613     DOI: 10.1007/bf01310563

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  83 in total

1.  DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus-1: regulation by nef.

Authors:  B Guy; B Acres; M P Kieny; J P Lecocq
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

2.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

3.  Human immunodeficiency virus type 1 negative factor is a transcriptional silencer.

Authors:  T M Niederman; B J Thielan; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.

Authors:  C A Rosen; E Terwilliger; A Dayton; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

5.  Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant.

Authors:  D S Threadgill; W K Steagall; M T Flaherty; F J Fuller; S T Perry; K E Rushlow; S F Le Grice; S L Payne
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.

Authors:  N Lewis; J Williams; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity.

Authors:  K Tomonaga; J Norimine; Y S Shin; M Fukasawa; T Miyazawa; A Adachi; T Toyosaki; Y Kawaguchi; C Kai; T Mikami
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

8.  The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.

Authors:  T Miyazawa; M Kohmoto; Y Kawaguchi; K Tomonaga; T Toyosaki; K Ikuta; A Adachi; T Mikami
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

9.  Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Authors:  T R Phillips; C Lamont; D A Konings; B L Shacklett; C A Hamson; P A Luciw; J H Elder
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

10.  The sor gene of HIV-1 is required for efficient virus transmission in vitro.

Authors:  A G Fisher; B Ensoli; L Ivanoff; M Chamberlain; S Petteway; L Ratner; R C Gallo; F Wong-Staal
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

View more
  14 in total

1.  Dynamics of two feline retroviruses (FIV and FeLV) within one population of cats.

Authors:  F Courchamp; C Suppo; E Fromont; C Bouloux
Journal:  Proc Biol Sci       Date:  1997-06-22       Impact factor: 5.349

2.  Functional central polypurine tract provides downstream protection of the human immunodeficiency virus type 1 genome from editing by APOBEC3G and APOBEC3B.

Authors:  Sebastien Wurtzer; Armelle Goubard; Fabrizio Mammano; Sentob Saragosti; Denise Lecossier; Allan J Hance; François Clavel
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 3.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

4.  Isolation of a highly cytopathic lentivirus from a nondomestic cat.

Authors:  M C Barr; L Zou; D L Holzschu; L Phillips; F W Scott; J W Casey; R J Avery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats.

Authors:  Y Inoshima; M Kohmoto; Y Ikeda; H Yamada; Y Kawaguchi; K Tomonaga; T Miyazawa; C Kai; T Umemura; T Mikami
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.

Authors:  M Amacker; M Hottiger; U Hübscher
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Sleep patterns are disturbed in cats infected with feline immunodeficiency virus.

Authors:  O Prospéro-García; N Herold; T R Phillips; J H Elder; F E Bloom; S J Henriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.

Authors:  E M Poeschla; D J Looney
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; M Kohmoto; Y Inoshima; K Maeda; T Mikami; K ] Maedadel K [corrected to Maeda
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.